On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Genius
The FDA approved biotech drug Benlysta to treat lupus, the first new treatment for the autoimmune disease in 50 years. It is also the first drug ever developed specifically to target the debilitating affliction. Call your broker.
A study in rats showed that poor nutrition during pregnancy caused a higher risk of disease for offspring in later life. An apple a day could keep the doctor away 50 years from now.
The last flight of shuttle Discovery marked the beginning of the end of the 30-year-old “space bus” program. After June’s final Atlantis mission, the U.S. will have to depend on Russia to get astronauts to the International Space Station. Holy Sputnik.
Gamblers beware: sleep deprivation may increase a sense of optimism, causing people to take bigger risks. No wonder casinos hand out free cigarettes and hide the clocks.
Self-proclaimed tiger-blooded, Adonis-DNAed warlock Charlie Sheen was labeled bipolar by “experts” who have never met him.
Folly
Subscribe to Support Independent Journalism
Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.
When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.
Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber
